India Designates New Medical Device Testing Officers: Understanding Notification S.O. 912(E)

India Designates New Medical Device Testing Officers: Understanding Notification S.O. 912(E)

The Indian regulatory landscape for healthcare products has taken another significant step toward streamlining quality control. On February 18, 2026, the Ministry of Health and Family Welfare (MoHFW) issued a pivotal CDSCO notification, designated as S.O. 912(E), which officially appoints a new cohort of Medical Device Testing Officers (MDTO) across the country.

This update is more than just a routine administrative change; it is a critical realignment of technical oversight for the medical technology sector.

The Legal Framework: Rule 18 and the 1940 Act

The CentralGovernment exercised its powers under Section 20(2) of the Drugs and Cosmetics Act 1940. When read alongside Rule 18(1) of the Medical Devices Rules 2017, this notification grants these officers the authority to test and analyze specific categories of medical equipment to ensure they meet national safety standards.

A key detail for compliance officers is that this notification officially supersedes S.O. 5331(E), which was dated December 10, 2024.

Designated Laboratories and Specialized Testing

The notification provides a comprehensive list of 27 experts stationed at India's premier testing facilities. Each laboratory is tasked with specific categories of devices, ensuring that testing is handled by subject-matter experts.

1. Central Drugs Laboratory (CDL), Kolkata

Focusing on foundational medical supplies, the officers here, including Dr. Saroj Kumar Ghosh and Dr. Rakesh Kumar Rishi, oversee:

●    Sterile & Single Use Medical Devices

●    Non-sterile Medical Devices

●     Surgical dressings

2. CDTL Mumbai and Chennai

These labs handle a broader range of mechanical and protective equipment:

●    Mechanical Contraceptives

●    Gloves for medical purposes

●     Disinfectants and Absorbent Gauge

3. National Institute of Biologicals (NIB), Noida

The NIB is the primary hub for high-tech diagnostics. Officers such as Dr. Akanksha Bisht and Dr. Rajesh Kumar Sharma are designated for:

● In-vitro Diagnostic (IVD) medical devices

● Biochemical and Molecular Diagnostic Kits

● Blood Grouping Reagents

Why This Matters for Manufacturers

For manufacturers and importers, knowing which Medical Device Testing Officers are active is essential for navigating the registration and quality-check process. Whether you are dealing with simple surgical dressings or complex molecular diagnostic kits, these designated analysts are the gatekeepers of market access in India.

The geographical spread from RDTL Guwahati to RDTL Chandigarh suggests a continued effort by the government to decentralize testing and reduce the turnaround time for device approvals.

Conclusion

The release of S.O. 912(E) serves as a reminder of the evolving nature of the Medical Devices Rules 2017. By staying updated on these CDSCO notifications, stakeholders can ensure their products remain compliant with the latest government standards.

As the medical device industry in India continues to grow, having a clear list of designated testing authorities provides much-needed clarity for both domestic innovation and international trade.

Looking for more regulatory updates? Keep an eye on our blog for the latest breakdowns of Indian pharmaceutical and medical device law.

Click here to know more and access the official guidance document

Note:
Cases related to Pharmaceuticals are highly technical and knowledge-driven. If you're searching for a drugs and cosmetics lawyer in India, a pharmaceutical lawyer, Mace Corporate Associates is the perfect place. If you are searching for a DPCO Lawyer for overcharging cases or DPCO Compliance, Mace can assist you well. May it be a clinical trial Lawyer or a Medical device lawyer, Mace can be of great and perfect match for Pharmaceutical litigation. Mace has an accomplished track record for Not of Standard Quality Cases, Licensing Cases etc.